Skip to main content
. 2021 Jan 11;6(2):e124–e135. doi: 10.1016/S2468-2667(20)30288-7

Table.

Percentage reductions in incidence and event rates of common mental illness, self-harm, antidepressant and benzodiazepine prescribing, and referrals to mental health services in the UK between March 1 and Sept 10, 2020

March 1–Sept 10, 2020
April 1–May 1, 2020
Observed frequency, n Expected frequency, n Percentage reduction (95% CI) Observed frequency, n Expected frequency, n Percentage reduction (95% CI)
England
Incidence (per 100 000 person-months)
Depression 53 443 62 032 13·8% (6·7 to 20·4) 4964 8724 43·0% (38·3 to 47·4)
Anxiety disorders 38 189 51 947 26·4% (21·4 to 31·2) 3807 7305 47·8% (44·3 to 51·2)
Antidepressants 93 845 113 575 17·3% (14·1 to 20·5) 10 512 16 537 36·4% (33·9 to 38·8)
Benzodiazepines 36 762 46 239 20·4% (17·7 to 23·1) 5510 6602 16·5% (13·6 to 19·3)
Self-harm 8512 10 388 18·0% (14·3 to 21·5) 920 1476 37·6% (34·8 to 40·3)
Event rate (per 100 000 person-months)
Antidepressants 7 237 716 7 573 286 4·4% (1·4 to 7·3) 1 031 928 1 120 229 7·8% (4·9 to 10·7)
Benzodiazepines 818 541 853 967 4·1% (1·5 to 6·7) 121 786 126 669 3·8% (1·2 to 6·4)
Self-harm 24 109 29 716 18·8% (15·8 to 21·7) 2666 4206 36·6% (34·2 to 38·8)
Northern Ireland, Scotland, and Wales
Incidence (per 100 000 person-months)
Depression 4601 8714 47·1% (44·1 to 50·1) 451 1305 65·4% (63·4 to 67·3)
Anxiety disorders 3655 6178 40·8% (38·1 to 43·3) 401 944 57·5% (55·5 to 59·3)
Antidepressants 18 081 24 817 27·1% (24·3 to 29·8) 2093 3824 45·2% (43·1 to 47·2)
Benzodiazepines 9342 11 480 18·6% (15·6 to 21·4) 1400 1706 17·9% (14·8 to 20·8)
Self-harm 1808 1988 9·0% (2·8 to 14·8) 230 305 24·5% (19·2 to 29·4)
Referral to mental health services 1337 2540 47·3% (44·7 to 49·8) 97 393 75·3% (74·0 to 76·4)
Event rate (per 100 000 person-months)
Antidepressants 1 721 824 1 803 768 4·5% (1·7 to 7·2) 257 671 278 751 7·5% (4·9 to 10·1)
Benzodiazepines 273 154 277 139 1·4% (−1·1 to 3·9) 42 717 42 996 0·6% (−1·9 to 3·2)
Self-harm 4433 4747 6·6% (1·2 to 11·7) 526 716 26·5% (22·3 to 30·6)